ROR1 and ROR2 expression in pancreatic cancer

Abstract Background The Wnt receptors ROR1 and ROR2 are generating increased interest as cancer therapeutic targets but remain understudied in pancreatic ductal adenocarcinoma (PDAC). Compared to canonical Wnt/ β-catenin signalling, the role of noncanonical Wnt signalling in PDAC remains largely unk...

Full description

Bibliographic Details
Main Authors: Dongli Liu, George Sharbeen, Phoebe Phillips, Australian Pancreatic Cancer Genome Initiative, Caroline E. Ford
Format: Article
Language:English
Published: BMC 2021-11-01
Series:BMC Cancer
Online Access:https://doi.org/10.1186/s12885-021-08952-9